Orbimed Advisors LLC Portfolio Holdings
Orbimed Advisors LLC
- $2.93 Billion
- Q3 2025
Orbimed Advisors LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $2.93 Billion distributed in 110 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $252M, Boston Scientific Corp with a value of $237M, Eli Lilly & CO with a value of $230M, Alnylam Pharmaceuticals, Inc. with a value of $138M, and Stryker Corp with a value of $133M.
Examining the 13F form we can see an increase of $129M in the current position value, from $2.8B to 2.93B.
Orbimed Advisors LLC is based out at San Diego, CA
Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.